Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease
Alzheimer's & Dementia · 2025-12 · 21 (12)
DOI: 10.1002/alz.71012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.12.2025. Verfasst von Wepnyu Yembe Njamnshi und 54 weiteren Autor:innen. Beteiligte Einrichtung: Global Brain Health Institute (GBHI), University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuropsychological Tests, Cognitive Dysfunction, Computers, Handheld. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: from NIH, NIA NIH HHS, from the Alzheimer's Association.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Brief digital cognitive measures may be a valuable and scalable alternative to traditional tests for improving early detection and disease monitoring in patients with early‐onset Alzheimer's disease (EOAD). METHODS We examined the convergent, diagnostic, and neuroanatomical validity of Tablet‐based Cognitive Assessment Tool (TabCAT) tests in the multisite Longitudinal Early‐Onset Alzheimer's Disease Study. Four hundred seventy‐five participants from 16 sites (83 cognitively unimpaired participants, 146 individuals diagnosed with mild cognitive impairment [MCI], and 246 with mild dementia) underwent TabCAT testing, including two executive/attentional tasks (Match and Flanker) and two visuospatial tasks (Line Length and Line Orientation). RESULTS TabCAT tests showed good convergent validity with traditional pen‐and‐paper tests. Match was the most accurate TabCAT test in differentiating among clinical groups (controls vs. MCI vs. dementia) and predicting amyloid positron emission tomography (PET) positivity in clinically impaired participants. TabCAT tests were associated with regional tau PET patterns. DISCUSSION TabCAT digital measures have promise for frontline identification of patients with EOAD. Highlights Four hundred seventy‐five participants from 16 US sites underwent tablet‐based cognitive assessment. Digital tests assessed executive function and visuospatial abilities. Digital tests correlated with traditional pen‐and‐paper cognitive tests. Match (test of executive function) differentiated clinical groups. Digital tests were associated with amyloid positron emission tomography (PET) status and regional tau PET patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Brain Health Institute (GBHI), University of California, San Francisco, San Francisco, California, USA.
- Brain Research Africa Initiative (BRAIN), Yaounde, Cameroon.
- Clinical Research Unit, Division of Operational Research, Ministry of Public Health, Yaounde, Cameroon.
- Department of Neurology, Edward and Pearl Fein Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
- Department of Psychology, University of Lomé, Lomé, Togo.
ORCID-Profile: Wepnyu Yembe Njamnshi, Konstantinos Chiotis, Elena Tsoy, Ganna Blazhenets, Piyush Maiti, Jiaxiuxiu Zhang, Bradford C Dickerson, Renaud La Joie
Förderung
- from NIH
- NIA NIH HHS
- from the Alzheimer's Association
- NINDS NIH HHS
Zitieren
APA
Njamnshi, W. Y., Chiotis, K., Tsoy, E., Blazhenets, G., Maiti, P., Zhang, J., Allen, I. E., Rocha, S., Shankar, R. P., Amuiri, A., Lawson, M., Aisen, P., Beckett, L., Eloyan, A., Hammers, D. B., Kirby, K., Koeppe, R., Kukull, W. A., Toga, A. W., …, & LEADS Consortium (2025). Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease. Alzheimer's & Dementia, 21(12). https://doi.org/10.1002/alz.71012
Vancouver
Njamnshi WY, Chiotis K, Tsoy E, Blazhenets G, Maiti P, Zhang J, et al. Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease. Alzheimer's & Dementia. 2025;21(12). doi:10.1002/alz.71012
BibTeX
@article{Njamnshi2025,
author = {Njamnshi, Wepnyu Yembe and Chiotis, Konstantinos and Tsoy, Elena and Blazhenets, Ganna and Maiti, Piyush and Zhang, Jiaxiuxiu and Allen, Isabel Elaine and Rocha, Salma and Shankar, Ranjani P and Amuiri, Alinda and Lawson, Mawuli and Aisen, Paul and Beckett, Laurel and Eloyan, Ani and Hammers, Dustin B and Kirby, Kala and Koeppe, Robert and Kukull, Walter A and Toga, Arthur W and Atri, Alireza and Clark, David and Day, Gregory S and Duara, Ranjan and Graff-Radford, Neill R and Grant, Ian and Honig, Lawrence S and Johnson, Erik C B and Jones, David T and Masdeu, Joseph and Mendez, Mario F and Musiek, Erik and Onyike, Chiadi U and Riddle, Meghan and Rogalski, Emily and Salloway, Steven and Sha, Sharon J and Turner, Raymond Scott and Wingo, Thomas S and Wolk, David A and Womack, Kyle and Kramer, Joel H and Touroutoglou, Alexandra and Brickhouse, Michael J and Jack, Clifford R and Vemuri, Prashanthi and Taurone, Alexander and Thangarajah, Maryanne and Nudelman, Kelly and Carrillo, Maria C and Dickerson, Bradford C and Apostolova, Liana G and Possin, Katherine L and Rabinovici, Gil D and La Joie, Renaud and LEADS Consortium, LEADS Consortium},
title = {Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {12},
doi = {10.1002/alz.71012}
}
EUVIMED